Evidence map›Paper›PMID 32104047›Full record

ArticlePharmacogenomics and personalized medicine2020

Li Li, Zhenjian Zhuo, Zhen Yang, Jinhong Zhu, Xiaoli He, Zhonghua Yang, Jiao Zhang, Yijuan Xin, Jing He, Tiesong Zhang

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmacogenomics and personalized medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Associations ofJournal of Cancer · 2026
    Article
  2. Article
  3. Aging · 2023
    Article
  4. Article
  5. Journal of Cancer · 2022
    Article
  6. Journal of Cancer · 2021
    Article
  7. Association ofPharmacogenomics and personalized medicine · 2021
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Li Li *Kunming Key Laboratory of Children's Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Institute of Pediatrics Research, Kunming Children's Hospital, Kunming, Yunnan, 650228, People's Republic of China.
Zhenjian Zhuo *Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, People's Republic of China.
Zhen Yang *Kunming Key Laboratory of Children's Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Institute of Pediatrics Research, Kunming Children's Hospital, Kunming, Yunnan, 650228, People's Republic of China.
Jinhong ZhuDepartment of Clinical Laboratory, Biobank, Harbin Medical University Cancer Hospital, Harbin 150040, Heilongjiang, People's Republic of China.
Xiaoli HeKunming Key Laboratory of Children's Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Institute of Pediatrics Research, Kunming Children's Hospital, Kunming, Yunnan, 650228, People's Republic of China.ORCID 0000-0003-4718-0048
Zhonghua YangDepartment of Pediatric Surgery, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning, People's Republic of China.
Jiao ZhangDepartment of Pediatric Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, People's Republic of China.
Yijuan XinClinical Laboratory Medicine Center of PLA, Xijing Hospital, Air Force Medical University, Xi'an 710032, Shaanxi, People's Republic of China.
Jing HeDepartment of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou 510623, Guangdong, People's Republic of China.ORCID 0000-0002-1954-2892
Tiesong ZhangKunming Key Laboratory of Children's Infection and Immunity, Yunnan Key Laboratory of Children's Major Disease Research, Yunnan Institute of Pediatrics Research, Kunming Children's Hospital, Kunming, Yunnan, 650228, People's Republic of China.
Kunming Children's Hospital · CNGuangzhou Medical University · CNFirst Affiliated Hospital of Zhengzhou University · CNHarbin Medical University · CNXijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHepatoblastoma is a rare disease. Its etiology remains obscure. No epidemiological reports have assessed the relationship of

methodsWe acquired samples from 275 hepatoblastoma cases and 1018 controls who visited one of five independent hospitals located in the different regions of China. The genotyping of

resultsIn the main analysis, we identified that rs968697 T>C polymorphism was significantly related to hepatoblastoma risk in the additive model (adjusted OR=0.73, 95% CI=0.54-0.98,

conclusionTo summarize, these results indicated that the

Indexed as

hepatoblastomaHMGA2polymorphismsusceptibility

Identifiers

PMID32104047
PMCPMC7023882
OpenAlexW3005049456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.